Rating History for Syros Pharmaceuticals (SYRS) by Brookline Capital Markets
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 11/13/2024 | Leah Rush Cann | Downgrade | Hold (Buy) |
N/A (N/A) |
2.73 (0.12) |
-95.6% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
